share_log

UnitedHealth | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

UnitedHealth | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

聯合健康 | FWP:自由書寫募資說明書
美股SEC公告 ·  07/25 00:03

牛牛AI助理已提取核心訊息

UnitedHealth Group Incorporated has finalized a substantial issuance of notes on July 23, 2024, totaling $10.5 billion across various maturities ranging from 2026 to 2064. The offering includes $500 million in floating rate notes due in 2026, and fixed-rate notes with interest rates from 4.750% to 5.750% due between 2026 and 2064. The notes were priced close to their principal amounts and will yield slightly higher than corresponding U.S. Treasury benchmarks. UnitedHealth intends to use the net proceeds for general corporate purposes. The notes, registered under SEC No. 333-270279, will settle on July 25, 2024. The offering was managed by a syndicate of banks, including Wells Fargo Securities and Citigroup Global Markets, among others. UnitedHealth's notes received ratings of A2 from Moody's, A+ from S&P, and A from Fitch, indicating a strong credit profile.
UnitedHealth Group Incorporated has finalized a substantial issuance of notes on July 23, 2024, totaling $10.5 billion across various maturities ranging from 2026 to 2064. The offering includes $500 million in floating rate notes due in 2026, and fixed-rate notes with interest rates from 4.750% to 5.750% due between 2026 and 2064. The notes were priced close to their principal amounts and will yield slightly higher than corresponding U.S. Treasury benchmarks. UnitedHealth intends to use the net proceeds for general corporate purposes. The notes, registered under SEC No. 333-270279, will settle on July 25, 2024. The offering was managed by a syndicate of banks, including Wells Fargo Securities and Citigroup Global Markets, among others. UnitedHealth's notes received ratings of A2 from Moody's, A+ from S&P, and A from Fitch, indicating a strong credit profile.
聯合健康集團於2024年7月23日完成了一筆總額爲105億美元的大規模發行,分別於2026年至2064年到期。該發行額包括2026年到期的5000萬美元浮息票據,以及2026年至2064年到期的利率爲4.750%至5.750%的固定利率票據。票據價格接近其本金並將產生略高於相應美國國債基準的收益率。聯合健康打算將淨收益用於一般企業用途。根據美國證券交易委員會註冊號333-270279進行註冊的票據將於2024年7月25日結算。該發行由銀行業銀行聯合管理,包括富國證券和花旗環球市場等。聯合健康的票據獲得了穆迪的A2評級,標準普爾的A +評級和惠譽的A評級,表明該公司信用狀況強勁。
聯合健康集團於2024年7月23日完成了一筆總額爲105億美元的大規模發行,分別於2026年至2064年到期。該發行額包括2026年到期的5000萬美元浮息票據,以及2026年至2064年到期的利率爲4.750%至5.750%的固定利率票據。票據價格接近其本金並將產生略高於相應美國國債基準的收益率。聯合健康打算將淨收益用於一般企業用途。根據美國證券交易委員會註冊號333-270279進行註冊的票據將於2024年7月25日結算。該發行由銀行業銀行聯合管理,包括富國證券和花旗環球市場等。聯合健康的票據獲得了穆迪的A2評級,標準普爾的A +評級和惠譽的A評級,表明該公司信用狀況強勁。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。